Mayne Pharma International (MPI) was formerly known as FH Faulding & Co Ltd, and is a specialist pharmaceutical company with an intellectual property portfolio built around the optimisation and delivery of oral dosage form drugs. MPI has a long and successful history in developing and commercialising improved pharmaceuticals, and has launched and marketed numerous products through partnerships with global licensees. MPI was acquired from Hospira by Halcygen in 2009. On 17 November 2010 at the Halcygen Annual General Meeting, Halcygen Pharmaceuticals changed its name to Mayne Pharma Group Limited trading..

Company was acquired by HalcyGen Pharmaceuticals